|
1
|
Universal definition of myocardial infarction.
|
Circulation
|
2007
|
11.69
|
|
2
|
Third universal definition of myocardial infarction.
|
J Am Coll Cardiol
|
2012
|
8.59
|
|
3
|
Third universal definition of myocardial infarction.
|
Circulation
|
2012
|
8.47
|
|
4
|
Third universal definition of myocardial infarction.
|
Eur Heart J
|
2012
|
7.98
|
|
5
|
Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
|
Lancet
|
2015
|
3.87
|
|
6
|
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.
|
Clin Chem
|
2005
|
2.43
|
|
7
|
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
|
Lancet
|
2013
|
2.39
|
|
8
|
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
|
JAMA
|
2008
|
2.39
|
|
9
|
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
|
Lancet
|
2010
|
2.38
|
|
10
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
|
Circulation
|
2007
|
2.37
|
|
11
|
Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.
|
Circulation
|
2006
|
2.09
|
|
12
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
|
Clin Chem
|
2007
|
1.82
|
|
13
|
Quality specifications for B-type natriuretic peptide assays.
|
Clin Chem
|
2005
|
1.81
|
|
14
|
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).
|
Am J Cardiol
|
2012
|
1.59
|
|
15
|
Evaluation of imprecision for cardiac troponin assays at low-range concentrations.
|
Clin Chem
|
2003
|
1.51
|
|
16
|
Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease.
|
Heart
|
2013
|
1.47
|
|
17
|
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
|
EuroIntervention
|
2011
|
1.43
|
|
18
|
Sex- and age-related differences in clinical outcome after primary percutaneous coronary intervention.
|
EuroIntervention
|
2012
|
1.42
|
|
19
|
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
|
Circulation
|
2007
|
1.39
|
|
20
|
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.
|
Clin Chem
|
2007
|
1.19
|
|
21
|
Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV).
|
Circulation
|
2012
|
1.17
|
|
22
|
Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.
|
J Am Coll Cardiol
|
2013
|
1.14
|
|
23
|
Randomized comparison of final kissing balloon dilatation versus no final kissing balloon dilatation in patients with coronary bifurcation lesions treated with main vessel stenting: the Nordic-Baltic Bifurcation Study III.
|
Circulation
|
2010
|
1.13
|
|
24
|
Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial.
|
J Am Coll Cardiol
|
2008
|
1.08
|
|
25
|
National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure.
|
Clin Chem
|
2007
|
1.08
|
|
26
|
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial.
|
J Am Coll Cardiol
|
2010
|
1.04
|
|
27
|
Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.
|
Circulation
|
2008
|
1.02
|
|
28
|
Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study.
|
Circ Cardiovasc Interv
|
2009
|
0.98
|
|
29
|
Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention.
|
Circ Cardiovasc Interv
|
2012
|
0.96
|
|
30
|
Outcome of sirolimus-eluting versus zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a SORT OUT III Substudy).
|
Am J Cardiol
|
2011
|
0.95
|
|
31
|
A pilot survey of the use and implementation of cardiac markers in acute coronary syndrome and heart failure across Europe. The CARdiac MArker Guideline Uptake in Europe (CARMAGUE) study.
|
Clin Chem Lab Med
|
2009
|
0.91
|
|
32
|
Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest--a systematic review and meta-analysis.
|
Resuscitation
|
2012
|
0.90
|
|
33
|
Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot study.
|
EuroIntervention
|
2013
|
0.89
|
|
34
|
Evidence-based laboratory medicine: how well do laboratories follow recommendations and guidelines? The Cardiac Marker Guideline Uptake in Europe (CARMAGUE) study.
|
Clin Chem
|
2011
|
0.88
|
|
35
|
Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome.
|
Am J Emerg Med
|
2010
|
0.87
|
|
36
|
2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial.
|
J Am Coll Cardiol
|
2012
|
0.86
|
|
37
|
Event detection using population-based health care databases in randomized clinical trials: a novel research tool in interventional cardiology.
|
Clin Epidemiol
|
2013
|
0.86
|
|
38
|
Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results.
|
EuroIntervention
|
2008
|
0.84
|
|
39
|
Primary percutaneous coronary intervention as a national reperfusion strategy in patients with ST-segment elevation myocardial infarction.
|
Circ Cardiovasc Interv
|
2011
|
0.84
|
|
40
|
Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
|
Am J Cardiol
|
2011
|
0.83
|
|
41
|
Comparison of outcomes of patients ≥ 80 years of age having percutaneous coronary intervention according to presentation (stable vs unstable angina pectoris/non-ST-segment elevation myocardial infarction vs ST-segment elevation myocardial infarction).
|
Am J Cardiol
|
2011
|
0.82
|
|
42
|
Clinical performance of a new point-of-care cardiac troponin I assay compared to three laboratory troponin assays.
|
Clin Chim Acta
|
2010
|
0.82
|
|
43
|
Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
|
JACC Cardiovasc Interv
|
2013
|
0.81
|
|
44
|
Kinetics of ischaemia modified albumin during ongoing severe myocardial ischaemia.
|
Clin Chim Acta
|
2009
|
0.81
|
|
45
|
Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
|
Int J Cardiol
|
2007
|
0.81
|
|
46
|
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy.
|
Eur J Clin Invest
|
2012
|
0.81
|
|
47
|
3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents.
|
JACC Cardiovasc Interv
|
2012
|
0.81
|
|
48
|
Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
|
Eur Heart J
|
2015
|
0.81
|
|
49
|
Haematoma after coronary angiography and percutaneous coronary intervention via the femoral artery frequency and risk factors.
|
Eur J Cardiovasc Nurs
|
2005
|
0.80
|
|
50
|
Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
|
Circ Cardiovasc Interv
|
2014
|
0.79
|
|
51
|
Determinants of the release pattern of ischaemia-modified albumin in acute ST-elevation myocardial infarction treated with primary PCI.
|
Scand J Clin Lab Invest
|
2010
|
0.78
|
|
52
|
Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
|
EuroIntervention
|
2010
|
0.78
|
|
53
|
The risk and prognostic impact of definite stent thrombosis or in-stent restenosis after coronary stent implantation.
|
EuroIntervention
|
2012
|
0.78
|
|
54
|
Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era.
|
Scand Cardiovasc J
|
2007
|
0.77
|
|
55
|
Rationale and design of a randomized clinical comparison of everolimus-eluting (Xience v/Promus) and sirolimus-eluting (cypher select+) coronary stents in unselected patients with coronary heart disease.
|
Cardiology
|
2010
|
0.77
|
|
56
|
[Coronary angiography should be considered after out-of-hospital cardiac arrest].
|
Ugeskr Laeger
|
2011
|
0.77
|
|
57
|
Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
|
JACC Cardiovasc Interv
|
2013
|
0.76
|
|
58
|
Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy).
|
BMC Cardiovasc Disord
|
2012
|
0.75
|
|
59
|
[Retirement of creatinine kinase myocardial band is not recommended].
|
Ugeskr Laeger
|
2008
|
0.75
|
|
60
|
A third troponin T blood sample is not cost-effective in patients with suspected non-ST segment elevation acute coronary syndrome.
|
Scand J Clin Lab Invest
|
2010
|
0.75
|
|
61
|
How well do laboratories follow guidelines on cardiac markers? The cardiac marker guideline uptake in Europe study.
|
Clin Chem
|
2008
|
0.75
|
|
62
|
Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic(R), Express(R), and Flexmaster(R) coronary stents.
|
EuroIntervention
|
2005
|
0.75
|
|
63
|
Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial.
|
EuroIntervention
|
2014
|
0.75
|
|
64
|
Extra corporeal life support makes advanced radiologic examinations and cardiac interventions possible in patients with cardiac arrest.
|
Resuscitation
|
2011
|
0.75
|
|
65
|
Do laboratories follow heart failure recommendations and guidelines and did we improve? The CARdiac MArker Guideline Uptake in Europe (CARMAGUE).
|
Clin Chem Lab Med
|
2013
|
0.75
|
|
66
|
Scintigraphic evaluation of routine filterwire distal protection in percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: a randomized controlled trial.
|
J Nucl Cardiol
|
2009
|
0.75
|
|
67
|
Quality assurance of the Western Denmark Heart Registry, a population-based healthcare register.
|
Dan Med J
|
2017
|
0.75
|
|
68
|
Biochemical diagnosis of myocardial infarction evolves towards ESC/ACC consensus: experiences from the Nordic countries.
|
Scand Cardiovasc J
|
2005
|
0.75
|